Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH; American Society of Clinical Oncology.

J Clin Oncol. 2001 Mar 1;19(5):1519-38.

PMID:
11230498
2.

Platelet transfusion trigger in difficult patients.

Rebulla P.

Transfus Clin Biol. 2001 Jun;8(3):249-54. Review. Erratum in: Transfus Clin Biol 2002 Jan;9(1):109.

PMID:
11499971
3.

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?

Stanworth SJ, Hyde C, Brunskill S, Murphy MF.

Br J Haematol. 2005 Dec;131(5):588-95. Review.

PMID:
16351634
4.

Current issues with platelet transfusion in patients with cancer.

McCullough J.

Semin Hematol. 2000 Apr;37(2 Suppl 4):3-10. Review.

PMID:
10831283
6.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

7.

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.

Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46. Review.

PMID:
16111570
8.

Thrombocytopenia and hemorrhagic risk in cancer patients.

Avvisati G, Tirindelli MC, Annibali O.

Crit Rev Oncol Hematol. 2003 Oct 15;48(Suppl):S13-6. Review.

PMID:
14563516
9.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

10.

Optimizing platelet transfusion therapy.

Heal JM, Blumberg N.

Blood Rev. 2004 Sep;18(3):149-65. Review.

PMID:
15183900
11.

Thrombocytopenia and platelet transfusions in patients with cancer.

Valent J, Schiffer CA.

Cancer Treat Res. 2011;157:251-65. doi: 10.1007/978-1-4419-7073-2_15. Review.

PMID:
21052961
12.

Platelet transfusion therapy.

Slichter SJ.

Hematol Oncol Clin North Am. 1990 Feb;4(1):291-311. Review.

PMID:
2179213
13.

Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?

Gajic O, Dzik WH, Toy P.

Crit Care Med. 2006 May;34(5 Suppl):S170-3. Review.

PMID:
16617262
14.
15.
16.

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.

Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel VG 3rd, Burstein HJ, Eisen A, Lipkus I, Pfister DG; American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group.

J Clin Oncol. 2002 Aug 1;20(15):3328-43. Review.

PMID:
12149307
17.

Thrombocytopenia in the neonate.

Roberts I, Stanworth S, Murray NA.

Blood Rev. 2008 Jul;22(4):173-86. doi: 10.1016/j.blre.2008.03.004. Epub 2008 Apr 22. Review.

PMID:
18433954
18.

Platelet transfusion and alternatives to transfusion in patients with malignancy.

Vaickus L, Breitmeyer JB, Schlossman RL, Anderson KC.

Stem Cells. 1995 Nov;13(6):588-96. Review.

PMID:
8590860
20.

Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review.

Hummel S, Paisley S, Morgan A, Currie E, Brewer N.

Health Technol Assess. 2003;7(33):iii, ix-x, 1-157. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk